Alexandros G. Panagiotopoulos

Athens, ESYE31, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Global perspectives on rheumatology training: insights from the EULAR 2025 EMEUNET Presents session.

Global perspectives on rheumatology training: insights from the EULAR 2025 EMEUNET Presents session.

Journal: EULAR rheumatology open

Published: June 29, 2026

Illness Perception in Axial Spondylarthritis: Bridging Mind and Joint.

Illness Perception in Axial Spondylarthritis: Bridging Mind and Joint.

Journal: International journal of rheumatic diseases

Published: October 20, 2025

Predictors of a successful glucocorticoid tapering and withdrawal in an inception cohort of patients with lupus nephritis and associations with long-term outcomes and damage accrual.

Predictors of a successful glucocorticoid tapering and withdrawal in an inception cohort of patients with lupus nephritis and associations with long-term outcomes and damage accrual.

Journal: RMD open

Published: May 07, 2025

Liver Injury Following Intravenous Methylprednisolone Pulse Therapy in Multiple Sclerosis: The Experience from a Single Academic Liver Center.

Liver Injury Following Intravenous Methylprednisolone Pulse Therapy in Multiple Sclerosis: The Experience from a Single Academic Liver Center.

Journal: Biomolecules

Published: January 16, 2025

Relapses and serious adverse events during rituximab maintenance therapy in ANCA-associated vasculitis: a multicentre retrospective study.

Relapses and serious adverse events during rituximab maintenance therapy in ANCA-associated vasculitis: a multicentre retrospective study.

Journal: Rheumatology (Oxford, England)

Published: June 02, 2024

Systemic Sclerosis Sine Scleroderma: A Time of Reappraisal.

Systemic Sclerosis Sine Scleroderma: A Time of Reappraisal.

Journal: The Journal of rheumatology

Published: May 30, 2024

Immunosuppressives discontinuation after renal response in lupus nephritis: predictors of flares, time to withdrawal and long-term outcomes.

Immunosuppressives discontinuation after renal response in lupus nephritis: predictors of flares, time to withdrawal and long-term outcomes.

Journal: Rheumatology (Oxford, England)

Published: April 07, 2024

Outcomes of COVID-19 re-infections: a single-center cohort of 167 patients with systemic rheumatic diseases.

Outcomes of COVID-19 re-infections: a single-center cohort of 167 patients with systemic rheumatic diseases.

Journal: Rheumatology international

Published: January 09, 2024

Efficacy of canakinumab in patients with Still's disease across different lines of biologic therapy: real-life data from the International AIDA Network Registry for Still's Disease.

Efficacy of canakinumab in patients with Still's disease across different lines of biologic therapy: real-life data from the International AIDA Network Registry for Still's Disease.

Journal: Frontiers in medicine

Published: July 10, 2023

Systemic Lupus Erythematosus and COVID-19.

Systemic Lupus Erythematosus and COVID-19.

Journal: Current rheumatology reports

Published: June 28, 2023

Omicron variant dominance and anti-SARS-CoV-2 vaccination are key determinants for a milder course of COVID-19 in patients with systemic autoimmune rheumatic diseases.

Omicron variant dominance and anti-SARS-CoV-2 vaccination are key determinants for a milder course of COVID-19 in patients with systemic autoimmune rheumatic diseases.

Journal: Clinical rheumatology

Published: June 02, 2023

Disease modification achievement in patients with lupus nephritis in a real-life setting: mission impossible?

Disease modification achievement in patients with lupus nephritis in a real-life setting: mission impossible?

Journal: RMD open

Published: March 14, 2023

Showing 1-12 of 22

Last Updated: 09/26/2026